Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT05432596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis (AD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b study to determine the safety, tolerability, pharmacokinetic (PK), and efficacy of ATI-1777 in patients 12 to 65 years old with mild to severe Atopic Dermatitis. Eligible participants will apply either ATI-1777 or Vehicle Topical Solution once daily or twice daily for 4 weeks.
Study identification
- NCT ID
- NCT05432596
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- ATI-1777 2.0% w/w Drug
- ATI-1777 1.0% w/w Drug
- ATI-1777 0.5% w/w Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2022 (Actual)
- Primary completion
- Oct 26, 2023 (Actual)
- Completion
- Nov 14, 2023 (Actual)
- Last update posted
- Oct 26, 2024
2022 – 2023
United States locations
- U.S. sites
- 32
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigational Site | Birmingham | Alabama | 35244 | — |
| Aclaris Investigational Site | Scottsdale | Arizona | 85255 | — |
| Aclaris Investigational Site | Bryant | Arkansas | 72022 | — |
| Aclaris Investigational Site | North Little Rock | Arkansas | 72117 | — |
| Aclaris Investigational Site | Encinitas | California | 92024 | — |
| Aclaris Investigational Site | Encino | California | 91436 | — |
| Aclaris Investigational Site | Castle Rock | Colorado | 80109 | — |
| Aclaris Investigational Site | Colorado Springs | Colorado | 80907 | — |
| Aclaris Investigational Site | Delray Beach | Florida | 33484 | — |
| Aclaris Investigational Site | Miami | Florida | 33173 | — |
| Aclaris Investigational Site | Miami Lakes | Florida | 33014 | — |
| Aclaris Investigational Site | Tampa | Florida | 33613 | — |
| Aclaris Investigational Site | West Palm Beach | Florida | 33401 | — |
| Aclaris Investigational Site | Sandy Springs | Georgia | 30328 | — |
| Aclaris Investigational Site | Normal | Illinois | 61761 | — |
| Aclaris Investigational Site | Skokie | Illinois | 60077 | — |
| Aclaris Investigational Site | Indianapolis | Indiana | 46250 | — |
| Aclaris Investigational Site | New Albany | Indiana | 47150 | — |
| Aclaris Investigational Site | West Lafayette | Indiana | 47906 | — |
| Aclaris Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| Aclaris Investigational Site | Houma | Louisiana | 70364 | — |
| Aclaris Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Aclaris Investigational Site | Wilmington | North Carolina | 28405 | — |
| Aclaris Investigational Site | Oklahoma City | Oklahoma | 73118 | — |
| Aclaris Investigational Site | Medford | Oregon | 97504 | — |
| Aclaris Investigational Site | Greenville | South Carolina | 29615 | — |
| Aclaris Investigational Site | Murfreesboro | Tennessee | 37130 | — |
| Aclaris Investigational Site | Arlington | Texas | 76011 | — |
| Aclaris Investigational Site | Dallas | Texas | 75230 | — |
| Aclaris Investigational Site | Houston | Texas | 77004 | — |
| Aclaris Investigational Site | San Antonio | Texas | 78213 | — |
| Aclaris Investigational Site | Richmond | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05432596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05432596 live on ClinicalTrials.gov.